Board of directors


Russell G. Greig

Chairman of the Board

Dr Greig has more than 35 years’ experience in the pharmaceutical industry, with knowledge and expertise in research and development, business development and commercial operations.


Joan Perelló

Managing director

Joan is managing director and co-founder of Sanifit. He has led several financing rounds at Sanifit and raised >€40m. With strong scientific background, he served as Chief Scientific officer at Sanifit from 2004 to 2013.


José Antonio Mesa


Jose Antonio is the Chief Investment Officer at Caixa Capital Risc. He specializes in investment in drug development and medical devices.

He currently serves on the Board of Directors at  Laboratoris Sanifit.


Joël Jean-Maire, PhDt

Managing Partner

Joël is managing partner and co-founder of Ysios Capital. Previously, he co-founded Glycart Biotechnology AG in 2001 and was its CEO until the company was successfully sold to F. Hoffmann La-Roche in 2005.


Casper Breum


Casper joined Lundbeckfond Ventures when established, in late 2009.
He is a member of the board of directors of Laboratoris Sanifit, Spero Therapeutics, Atox Bio, Biom’Up, and Dysis Medical.


Geert-Jan Mulder


Geert-Jan Mulder, MD, co-founded Forbion in 2006, currently serves on the Board of several Forbion portfolio companies: AM-Pharma (USD 600 million option deal with Pfizer), Promedior Inc.


Edwin de Graaf


Edwin de Graaf , co-founder and Managing Director of Gilde Healthcare, joined Gilde Investment Management in 1997 as an investment manager of Strategic Situations.


Naveed Siddiqi


Naveed Siddiqi is a Partner at Edmond de Rothschild Investment Partners (EDRIP). He focuses on investments in biotechnology and medtech companies.


Marisa Guitart

Board Observer

Marisa is an international management consultant and project director who has mainly specialized in the life sciences and medical devices sectors for more than 30 years.